Ameriprise’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.78M | Sell |
|
|||||
|
2025
Q2 | $5.43M | Sell |
|
|||||
|
2025
Q1 | $6.53M | Sell |
|
|||||
|
2024
Q4 | $5.9M | Buy |
|
|||||
|
2024
Q3 | $5.52M | Sell |
|
|||||
|
2024
Q2 | $4.91M | Sell |
|
|||||
|
2024
Q1 | $6.08M | Sell |
|
|||||
|
2023
Q4 | $7.6M | Buy |
|
|||||
|
2023
Q3 | $4.87M | Sell |
|
|||||
|
2023
Q2 | $5.87M | Sell |
|
|||||
|
2023
Q1 | $7.55M | Sell |
|
|||||
|
2022
Q4 | $11.8M | Buy |
|
|||||
|
2022
Q3 | $7.99M | Buy |
|
|||||
|
2022
Q2 | $1.46M | Buy |
|
|||||
|
2022
Q1 | $1.63M | Sell |
|
|||||
|
2021
Q4 | $3.65M | Buy |
|
|||||
|
2021
Q3 | $324K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $50K | Hold |
|
|||||
|
2020
Q4 | $37K | Sell |
|
|||||
|
2020
Q3 | $86K | Buy |
|
|||||
|
2020
Q2 | $124K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1.34M | Buy |
|